Market overview
The global wound care market is worth USD 26.5 bn in 2026 and is forecast to reach USD 47.5 bn by 2036, growing at a 6.0% CAGR. United States is the largest country market and Advanced dressings is the largest by product segment.
| Scope | Products for treating acute and chronic wounds: advanced dressings, traditional dressings, negative pressure systems, skin substitutes, compression therapy and wound care biologics. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 25.0 bn |
| Value 2026 | USD 26.5 bn |
| Value 2036 | USD 47.5 bn |
| CAGR 2026-2036 | 6.0% |
| Volume 2026 | 3,164 million units |
| Volume 2036 | 5,391 million units |
| Average price 2026 | USD 8.38 per unit |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Wound Care market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 26.5 bn |
| 2027 | USD 28.1 bn |
| 2028 | USD 29.8 bn |
| 2029 | USD 31.6 bn |
| 2030 | USD 33.5 bn |
| 2031 | USD 35.5 bn |
| 2032 | USD 37.6 bn |
| 2033 | USD 39.8 bn |
| 2034 | USD 42.2 bn |
| 2035 | USD 44.8 bn |
| 2036 | USD 47.5 bn |
Wound Care market segmentation
By product
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Advanced dressings | 42.0% | 42.0% | USD 11.1 bn | 6.0% |
| Traditional dressings | 20.0% | 14.3% | USD 5.3 bn | 2.5% |
| Negative pressure wound therapy | 14.0% | 16.1% | USD 3.7 bn | 7.5% |
| Biologics and skin substitutes | 12.0% | 16.6% | USD 3.2 bn | 9.5% |
| Compression and others | 12.0% | 10.9% | USD 3.2 bn | 5.0% |
By wound type
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Chronic wounds | 55.0% | 58.0% | USD 14.6 bn | 6.6% |
| Surgical wounds | 25.0% | 22.9% | USD 6.6 bn | 5.1% |
| Burns and trauma | 20.0% | 19.2% | USD 5.3 bn | 5.6% |
By end user
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Hospitals | 44.0% | 41.0% | USD 11.7 bn | 5.2% |
| Home healthcare | 24.0% | 27.0% | USD 6.4 bn | 7.3% |
| Specialty wound clinics | 14.0% | 15.0% | USD 3.7 bn | 6.7% |
| Nursing and long-term care | 12.0% | 12.0% | USD 3.2 bn | 6.0% |
| Ambulatory surgical centres | 6.0% | 5.0% | USD 1.6 bn | 4.1% |
By distribution channel
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Hospital procurement and tenders | 38.0% | 35.0% | USD 10.1 bn | 5.1% |
| Retail pharmacies | 22.0% | 20.0% | USD 5.8 bn | 5.0% |
| Online and e-commerce | 14.0% | 19.0% | USD 3.7 bn | 9.3% |
| Direct to providers | 26.0% | 26.0% | USD 6.9 bn | 6.0% |
By price tier
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Premium advanced products | 34.0% | 37.0% | USD 9.0 bn | 6.9% |
| Mid-range products | 41.0% | 40.0% | USD 10.9 bn | 5.7% |
| Value and generic products | 25.0% | 23.0% | USD 6.6 bn | 5.1% |
Top 25 countries for wound care by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 75.0% of 2026 revenue and the 25 countries below together hold 93.2%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 9.5 bn | 36.0% | USD 17.5 bn | 6.3% |
| 2 | China | USD 2.1 bn | 8.0% | USD 4.7 bn | 8.3% |
| 3 | Germany | USD 1.6 bn | 6.0% | USD 2.5 bn | 4.7% |
| 4 | Japan | USD 1.6 bn | 6.0% | USD 2.3 bn | 3.7% |
| 5 | United Kingdom | USD 1.1 bn | 4.0% | USD 1.7 bn | 4.9% |
| 6 | France | USD 1.1 bn | 4.0% | USD 1.7 bn | 4.9% |
| 7 | Italy | USD 795 mn | 3.0% | USD 1.3 bn | 4.9% |
| 8 | India | USD 795 mn | 3.0% | USD 1.9 bn | 8.8% |
| 9 | Brazil | USD 662 mn | 2.5% | USD 1.3 bn | 6.8% |
| 10 | Canada | USD 662 mn | 2.5% | USD 1.1 bn | 5.1% |
| 11 | Australia | USD 631 mn | 2.4% | USD 1.1 bn | 5.8% |
| 12 | Spain | USD 580 mn | 2.2% | USD 1.0 bn | 5.8% |
| 13 | Netherlands | USD 464 mn | 1.8% | USD 816 mn | 5.8% |
| 14 | Turkey | USD 398 mn | 1.5% | USD 769 mn | 6.8% |
| 15 | Mexico | USD 350 mn | 1.3% | USD 679 mn | 6.8% |
| 16 | Saudi Arabia | USD 318 mn | 1.2% | USD 612 mn | 6.8% |
| 17 | Switzerland | USD 292 mn | 1.1% | USD 484 mn | 5.2% |
| 18 | Poland | USD 270 mn | 1.0% | USD 522 mn | 6.8% |
| 19 | Belgium | USD 254 mn | 1.0% | USD 418 mn | 5.1% |
| 20 | Sweden | USD 238 mn | 0.9% | USD 394 mn | 5.2% |
| 21 | Austria | USD 228 mn | 0.9% | USD 375 mn | 5.1% |
| 22 | Russia | USD 217 mn | 0.8% | USD 361 mn | 5.2% |
| 23 | Argentina | USD 207 mn | 0.8% | USD 365 mn | 5.9% |
| 24 | Thailand | USD 199 mn | 0.8% | USD 384 mn | 6.8% |
| 25 | Israel | USD 191 mn | 0.7% | USD 370 mn | 6.8% |
| Rest of world | USD 1.8 bn | 6.8% | USD 2.9 bn | 4.8% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Smith and Nephew
- Solventum
- Molnlycke Health Care
- Convatec
- Coloplast
- Cardinal Health
Group 2: Regional and specialist players
- Paul Hartmann
- Essity
- Medline
- Integra LifeSciences
- Organogenesis
- MiMedx
- Lohmann and Rauscher
- DeRoyal Industries
Group 3: Emerging and niche players
- Hollister
- Urgo Medical
- Winner Medical
- Advanced Medical Solutions
- Sanara MedTech
- Avita Medical
- Tissue Regenix
- Crawford Healthcare
- Kerecis
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the wound care market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 6.0% is calculated from the resulting values.
The market is divided by product, by wound type, by end user, by distribution channel, by price tier. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the wound care market?
The global wound care market is estimated at USD 25.0 bn in 2025 and USD 26.5 bn in 2026.
How fast will the wound care market grow?
It is forecast to reach USD 47.5 bn by 2036, a compound annual growth rate of 6.0% from 2026, an increase of USD 21.0 bn.
Which country is the largest market for wound care?
United States is the largest market by revenue at USD 9.5 bn in 2026, 36.0% of the global total. The three largest countries together hold 50.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 8.8% a year from 2026 to 2036.
Which wound care segment is largest?
In the by product split, Advanced dressings is the largest segment with 42.0% of 2026 revenue.
Who are the leading wound care companies?
Global leaders include Smith and Nephew, Solventum, Molnlycke Health Care, Convatec.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Drug Discovery ServicesUSD 26.4 bn · 10.5% CAGR
- Remote Patient MonitoringUSD 25.7 bn · 16.0% CAGR
- Cell CultureUSD 23.9 bn · 8.0% CAGR
- Ocular Drug DeliveryUSD 29.7 bn · 6.0% CAGR
- Oral Drug DeliveryUSD 22.6 bn · 7.5% CAGR
- Regenerative MedicineUSD 31.6 bn · 13.0% CAGR
- Biopharmaceutical LogisticsUSD 21.7 bn · 9.0% CAGR
- Molecular DiagnosticsUSD 32.4 bn · 8.0% CAGR